Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Flatiron Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11151
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate information systems to produce a view of the patient population; oncoEMR which helps organizations to optimize clinical decision making process and supports data collection and reporting; oncobilling, a practice management system integrates into oncoEMR to provide insights into financial viability of practice; oncoanalytics platform helps organizations to extract meaningful insights from data; oncotrails solution allows firms to manage their clinical trial programs. Flatiron Health caters services to oncologists, academics, hospitals, life science researchers, and regulatory bodies. Flatiron Health is headquartered in New York, the US.

Flatiron Health Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Flatiron Health Raises USD175 Million in Series C Financing 11
Flatiron Health Raises US$130 Million In Series B Financing 13
Partnerships 15
Bristol-Myers Squibb Expands Collaboration with Flatiron Health 15
Flatiron Health Enters into Research Agreement with US Food and Drug Administration 16
Flatiron Health Partners with Celgene 17
Flatiron Health Partners with Amgen 18
Guardant Health Enters into Agreement with Flatiron Health 19
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 20
Acquisition 21
Roche Acquires Flatiron Health for USD1.9 Billion 21
Flatiron Health Inc – Key Competitors 22
Flatiron Health Inc – Key Employees 23
Flatiron Health Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Apr 03, 2017: Flatiron Health Announces Former Groupon and Google Executive Jason Harinstein to Join as Chief Financial Officer 25
Government and Public Interest 26
May 14, 2018: Pivotal Study Validates Real-World Mortality Endpoint for Oncology Research 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Flatiron Health Inc, Pharmaceuticals & Healthcare, Key Facts 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flatiron Health Raises USD175 Million in Series C Financing 11
Flatiron Health Raises US$130 Million In Series B Financing 13
Bristol-Myers Squibb Expands Collaboration with Flatiron Health 15
Flatiron Health Enters into Research Agreement with US Food and Drug Administration 16
Flatiron Health Partners with Celgene 17
Flatiron Health Partners with Amgen 18
Guardant Health Enters into Agreement with Flatiron Health 19
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 20
Roche Acquires Flatiron Health for USD1.9 Billion 21
Flatiron Health Inc, Key Competitors 22
Flatiron Health Inc, Key Employees 23
Flatiron Health Inc, Other Locations 24

List of Figures
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Flatiron Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Flatiron Health Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Smiths Group Plc (SMIN):企業の財務・戦略的SWOT分析
    Smiths Group Plc (SMIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Great-West Lifeco Inc.:企業の戦略・SWOT・財務情報
    Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report Summary Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wintac Ltd (524758):企業の財務・戦略的SWOT分析
    Summary Wintac Ltd (Wintac), formerly Recon Ltd is a manufacturer and marketer of sterile products. The company offers opthalmic products such as anti-glaucoma, anti-cholinergic, artificial tear, NSAID, steroids and combination, anti-infective, decongestant, anti allergic eye drops and nasal drop, a …
  • Titanium Metals Corp:企業の戦略・SWOT・財務分析
    Titanium Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Titanium Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NORDSEE GmbH.:戦略・SWOT・企業財務分析
    NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report Summary NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Trammo Inc:企業の戦略的SWOT分析
    Trammo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Kerecis ehf:製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • Servest Group Ltd:企業の戦略的SWOT分析
    Servest Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Dynasil Corporation of America (DYSL):企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …
  • FalconStor Software Inc (FALC):企業の財務・戦略的SWOT分析
    Summary FalconStor Software Inc (FalconStor) is a technology company that offers data protection and storage virtualization solutions. The company offers freestor, continuous data protector, and network storage server. It offers freestor, which supports to manage data to deliver real-time informatio …
  • Proteus Digital Health Inc-医療機器分野:企業M&A・提携分析
    Summary Proteus Digital Health Inc (Proteus) is a medical device company which develops and sells digital medicine for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digita …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits …
  • Birlasoft Ltd (BSOFT):企業の財務・戦略的SWOT分析
    Birlasoft Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DH Private Equity Partners:企業の戦略・SWOT・財務情報
    DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report Summary DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bucher Industries AG:企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Neste Engineering Solutions Oy:企業の戦略的SWOT分析
    Neste Engineering Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆